Algert Global LLC Buys Shares of 33,570 CytomX Therapeutics, Inc. (NASDAQ:CTMX)
Algert Global LLC purchased a new position in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 33,570 shares of the biotechnology company’s stock, valued at approximately $35,000. A number of other institutional investors also […]
Algert Global LLC purchased a new position in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 33,570 shares of the biotechnology company’s stock, valued at approximately $35,000. A number of other institutional investors also […]
